Differences in Diabetic Prescription Drug Utilization and Costs among Patients with Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015

Importance: Increasing prices of antidiabetic medications in the US have raised substantial concerns about the effects of drug affordability on diabetes care. There has been little rigorous evidence comparing the experiences of patients with diabetes across different types of insurance coverage. Obj...

Full description

Bibliographic Details
Main Authors:	Allen, H.L (Author), Bhanja, A. (Author), Kesselheim, A.S (Author), Khorrami, P. (Author), Sinha, M.S (Author), Sommers, B.D (Author)
Format:	Article
Language:	English
Published:	American Medical Association 2022
Subjects:	adult Adult antidiabetic agent Article Colorado controlled study Cross-Sectional Studies cross-sectional study demography diabetes mellitus Diabetes Mellitus, Type 2 diabetic patient dipeptidyl peptidase IV inhibitor disease duration drug cost Drug Costs drug utilization economics fee female Female glucagon like peptide 1 receptor agonist health insurance hospital patient human human insulin Humans Hypoglycemic Agents insulin insulin aspart insulin detemir insulin glargine insulin lispro insurance Insurance Coverage isophane insulin lowest income group major clinical study male Male medicaid Medicaid metformin middle aged Middle Aged non insulin dependent diabetes mellitus observational study outcome assessment outpatient poverty Poverty poverty level prescription prescription drug Prescription Fees recombinant human insulin sodium glucose cotransporter 2 inhibitor sulfonylurea derivative treatment outcome United States young adult Young Adult
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Differences in Diabetic Prescription Drug Utilization and Costs among Patients with Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015

Internet

Similar Items